StonvexLoading…
StonvexStonvexStonvexCore line items from CHGG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $376.91M | $617.57M | $716.29M | $766.90M |
Operating Income | $-116.86M | $-737.11M | $-67.72M | $8.96M |
Net Income | $-103.42M | $-837.07M | $18.18M | $266.64M |
EPS (Diluted) | $-0.96 | $-8.10 | $-0.34 | $1.34 |
Total Assets | $278.01M | $868.95M | $1.73B | $2.47B |
Total Liabilities | $158.39M | $675.97M | $782.62M | $1.35B |
Cash & Equivalents | $31.15M | $161.47M | $135.76M | $473.68M |
Free Cash Flow OCF − CapEx | $-12.63M | $50.25M | $163.15M | $152.64M |
Shares Outstanding | 110.99M | 104.88M | 102.82M | 126.47M |